Joined Today: 3

ACHN Achillion Pharmaceuticals,, Stock Message Board

All Messages

#4: Achillion and FOB Synthesis Announce Collaboration for the Development of Carbapenem Compounds
NewsBot	April 13, 2008 03:49:15 PM
Achillion and FOB Synthesis Announce Collaboration for the Development of Carbapenem Compounds NEW HAVEN, Conn. and KENNESAW, Ga., April 8, 2008... view message ignore post recommend post

#3: New Data for Achillion's Elvucitabine Demonstrate Drug's Safety, Efficacy and Suitability for Combination Therapy in HIV-Infected Patients
TheMachine	February 10, 2008 06:21:23 AM
NEW HAVEN, Conn., Jan. 31, 2008 (PRIME NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development... view message ignore post recommend post

#2: Achillion Reports Safety and Potent Antiviral Activity in Topline Results From Elvucitabine Phase 2 Study in HIV-Infected Patients
FastFun	October 15, 2007 11:50:48 PM
NEW HAVEN, Conn., Oct. 15, 2007 (PRIME NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most... view message ignore post recommend post

#1: ACHN, Achillion Announces the Resignation of John C. Pottage, Jr., M.D., Senior Vice President and Chief Medical Officer
Jason	June 4, 2007 08:23:18 AM
Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN Stock Forum) today announced that John C. Pottage, Jr., M.D., Senior Vice President and Chief Medical Officer, has resigned to accept a senior clinical... view message ignore post recommend post

Group Home | Login if you want to post a message